Zobrazeno 1 - 10
of 99
pro vyhledávání: '"Elena Lukina"'
P566: RESULTS OF NON-CHEMOTERAPEUTIC TREATMENT OF PATIENTS WITH DE NOVO ACUTE PROMYELOCYTIC LEUKEMIA
Autor:
Vera Troitskaya, Arina Semenova, Zalina Fidarova, Andrey Sokolov, Irina Lukyanova, Olga Aleshina, Gennady Galstyan, Elena Gribanova, Elena Lukina, Valentina Dvirnyk, Tatyana Obukhova, Andrey Sudarikov, Sergey Kulikov, Elena Parovichnikova
Publikováno v:
HemaSphere, Vol 7, p e472873a (2023)
Externí odkaz:
https://doaj.org/article/0cac7ec8d2934821b094f2b638006b86
Publikováno v:
HemaSphere, Vol 7, p e431685d (2023)
Externí odkaz:
https://doaj.org/article/dc889f8bf76d44548bb8b5f9d43af400
Autor:
Imre Bodó, Ismail Amine, Ana Boban, Horia Bumbea, Alexander Kulagin, Elena Lukina, Agnieszka Piekarska, Irena Preloznik Zupan, Juraj Sokol, Jerzy Windyga, Jaroslav Cermak
Publikováno v:
Advances in Therapy. 40:2752-2772
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b619760f0c46ae027a167dcb60cd6c47
https://doi.org/10.1007/s12325-023-02510-4
https://doi.org/10.1007/s12325-023-02510-4
Autor:
Arkadii Kazmin, Kirill Savost'anov, Savostyanov, Mamonov Vasily, Nataliia Morozova, Alexander Potapov, Elena Lukina
Publikováno v:
Pediatria. Journal named after G.N. Speransky. 101:157-163
Gaucher disease (GD) is an autosomal recessive genetic disease characterized by the accumulation of glucocerebroside in the lysosomes of macrophages of the reticuloendothelial system with the development of cytopenia, hepatosplenomegaly, bone lesions
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f681c2b5d61ee138eff1be8bc3f56687
https://doi.org/10.24110/0031-403x-2022-101-5-157-163
https://doi.org/10.24110/0031-403x-2022-101-5-157-163
Autor:
Elena Lukina, Mario Menschikowski, Albert Hagelgans, Gjumrakch Aliev, Markus Friedemann, Olga A. Sukocheva
Publikováno v:
Seminars in Cancer Biology. 82:35-59
Breast cancer (BC) cell de-sensitization to Tamoxifen (TAM) or other selective estrogen receptor (ER) modulators (SERM) is a complex process associated with BC heterogeneity and the transformation of ER signalling. The most influential resistance-rel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cd2276989737b241f6b3b0c9af067b0d
https://doi.org/10.1016/j.semcancer.2020.12.004
https://doi.org/10.1016/j.semcancer.2020.12.004
Publikováno v:
Eduweb. 15:204-214
The purpose of the article is to analyze the experience of modeling the educational and training process for training volleyball players. Methodology: the research is carried out on the example of volleyball players' educational-training process form
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::15741bc57803fb91ba9fba974b9090fa
https://doi.org/10.46502/issn.1856-7576/2021.15.03.17
https://doi.org/10.46502/issn.1856-7576/2021.15.03.17
Publikováno v:
Journalism & Mass Communication Educator. 77:74-91
The COVID-19 pandemic affected education worldwide, and journalism faculties and students were not exceptions. In the Russian Federation, all educational institutions, including journalism schools, were obliged with 1 day’s notice to switch their c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::76d87d9f6381e18be2b670c0c7bbf281
https://doi.org/10.1177/10776958211053675
https://doi.org/10.1177/10776958211053675
Autor:
Sebastiaan J.M. Gaemers, Pramod K. Mistry, Joel Charrow, Theodore Marinakis, Meredith C. Foster, Timothy M. Cox, M. Judith Peterschmitt, Elena Lukina
Debilitating bone complications are common among patients with Gaucher disease type 1 (GD1). We analyzed changes in bone parameters among 393 GD1 patients treated with oral eliglustat for 4–8 years in 4 Sanofi Genzyme-sponsored clinical trials (Pha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::20c5446ad43678bf72d667b32ead022f
Autor:
Pramod K. Mistry, Evgueniy Hadjiev, Sebastiaan J.M. Gaemers, Suma P. Shankar, Marwan Ghosn, Sarit Assouline, Andres Ortega, Heather Lau, Seymour Packman, Sumita Danda, Elena Lukina, M. Judith Peterschmitt, Hagit Baris Feldman, Milan Petakov, Hadhami Ben Turkia, Meredith C. Foster, Atul Mehta, Manisha Balwani
Publikováno v:
American Journal of Hematology
Eliglustat, an oral substrate reduction therapy, is approved for eligible adults with Gaucher disease type 1. In the Phase 3 ENGAGE trial of previously untreated adults with Gaucher disease type 1, eliglustat‐treated patients had statistically sign
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f9d0cc53d5ab38cd4fb6f6b75864b4a
https://doi.org/10.1002/ajh.26276
https://doi.org/10.1002/ajh.26276
Autor:
R V Ponomarev, Elena Lukina
Publikováno v:
Терапевтический архив, Vol 93, Iss 7, Pp 830-836 (2021)
Gaucher disease (GD) is the most common lysosomal storage disorder, resulting from a deficiency in the activity of a lysosomal enzyme glucocerebrosidase, which is involved in the catabolism of sphingolipids. The phenomenal progress in understanding t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6061ce8b94f41e1eda560ed7685ed924
https://ter-arkhiv.ru/0040-3660/article/viewFile/76364/56963
https://ter-arkhiv.ru/0040-3660/article/viewFile/76364/56963